Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
Margarita BridaMassimo ChessaDavid CelermajerWei LiTal GevaPaul KhairyMassimo GriselliHelmut BaumgartnerMichael A GatzoulisPublished in: European heart journal (2021)
Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed in adulthood. Although considered a simple defect, challenges in optimal diagnostic and treatment options still exist due to great heterogeneity in terms of anatomy and time-related complications primarily arrhythmias, thromboembolism, right heart failure and, in a subset of patients, pulmonary arterial hypertension (PAH). Atrial septal defects call for tertiary expertise where all options may be considered, namely catheter vs. surgical closure, consideration of pre-closure ablation for patients with atrial tachycardia and suitability for closure or/and targeted therapy for patients with PAH. This review serves to update the clinician on the latest evidence, the nuances of optimal diagnostics, treatment options, and long-term follow-up care for patients with an ASD.
Keyphrases
- catheter ablation
- congenital heart disease
- atrial fibrillation
- pulmonary arterial hypertension
- left atrial
- heart failure
- end stage renal disease
- pulmonary artery
- depressive symptoms
- pulmonary hypertension
- newly diagnosed
- healthcare
- chronic kidney disease
- autism spectrum disorder
- ejection fraction
- palliative care
- left ventricular
- hypertrophic cardiomyopathy
- risk factors
- attention deficit hyperactivity disorder
- peritoneal dialysis
- polycyclic aromatic hydrocarbons
- coronary artery
- patient reported outcomes
- chronic pain
- intellectual disability
- drug delivery
- acute heart failure